Aronia berry polyphenol consumption reduces plasma total and low-density lipoprotein cholesterol in former smokers without lowering biomarkers of inflammation and oxidative stress: a randomized controlled trial
- PMID: 28215316
- DOI: 10.1016/j.nutres.2016.12.007
Aronia berry polyphenol consumption reduces plasma total and low-density lipoprotein cholesterol in former smokers without lowering biomarkers of inflammation and oxidative stress: a randomized controlled trial
Abstract
Former smokers are at increased risk for cardiovascular disease. We hypothesized that dietary aronia polyphenols would reduce biomarkers of cardiovascular disease risk, inflammation, and oxidative stress in former smokers. We also determined the extent these effects were associated with polyphenol bioavailability. A 12-week, randomized, placebo-controlled trial was conducted in 49 healthy adult former smokers (n = 24/placebo, n = 25/aronia) to evaluate if daily consumption of 500 mg aronia extract modulated plasma lipids, blood pressure, biomarkers of inflammation and oxidative stress, and lipid transport genes of peripheral blood mononuclear cells. The primary outcome was change in low-density lipoprotein cholesterol (LDL-C) from baseline, and multivariate correlation analysis was performed to determine if changes in lipids were associated with urinary polyphenol excretion. Aronia consumption reduced fasting plasma total cholesterol by 8% (P = .0140), LDL-C by 11% (P = .0285), and LDL receptor protein in peripheral blood mononuclear cells (P = .0036) at 12 weeks compared with the placebo group. Positive changes in the urinary polyphenol metabolites peonidin-3-O-galactoside, 3-(4-hydroxyphenyl) propionic acid, and unmetabolized anthocyanin cyanidin-3-O-galactoside were associated with lower plasma total cholesterol and LDL-C in the aronia group. Aronia consumption did not change blood pressure or biomarkers of inflammation and oxidative stress. Aronia polyphenols reduced total and LDL-C in former smokers but did not improve biomarkers of oxidative stress and chronic inflammation. The cholesterol-lowering activity of aronia extract was most closely associated with urinary levels of cyanidin-3-O-galactoside and peonidin-3-O-galactoside, its methylated metabolite. This trial was registered at ClinicalTrials.gov as NCT01541826.
Keywords: Anthocyanins; Aronia; Cholesterol; Clinical trial; Former smokers; Inflammation; Oxidative stress.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Daily supplementation with aronia melanocarpa (chokeberry) reduces blood pressure and cholesterol: a meta analysis of controlled clinical trials.J Diet Suppl. 2021;18(5):517-530. doi: 10.1080/19390211.2020.1800887. Epub 2020 Aug 14. J Diet Suppl. 2021. PMID: 32794414 Review.
-
Chokeberry Juice Containing Polyphenols Does Not Affect Cholesterol or Blood Pressure but Modifies the Composition of Plasma Phospholipids Fatty Acids in Individuals at Cardiovascular Risk.Nutrients. 2019 Apr 15;11(4):850. doi: 10.3390/nu11040850. Nutrients. 2019. PMID: 30991718 Free PMC article. Clinical Trial.
-
Fruits of Black Chokeberry Aronia melanocarpa in the Prevention of Chronic Diseases.Molecules. 2017 Jun 7;22(6):944. doi: 10.3390/molecules22060944. Molecules. 2017. PMID: 28590446 Free PMC article. Review.
-
Bioavailability of anthocyanins and colonic polyphenol metabolites following consumption of aronia berry extract.Food Chem. 2016 Nov 15;211:860-8. doi: 10.1016/j.foodchem.2016.05.122. Epub 2016 May 19. Food Chem. 2016. PMID: 27283706 Clinical Trial.
-
A Randomized Clinical Trial Evaluating the Efficacy of an Anthocyanin-Maqui Berry Extract (Delphinol®) on Oxidative Stress Biomarkers.J Am Coll Nutr. 2015;34 Suppl 1:28-33. doi: 10.1080/07315724.2015.1080108. J Am Coll Nutr. 2015. PMID: 26400431 Clinical Trial.
Cited by
-
Effects of Anthocyanins on Components of Metabolic Syndrome-A Review.Nutrients. 2024 Apr 9;16(8):1103. doi: 10.3390/nu16081103. Nutrients. 2024. PMID: 38674794 Free PMC article. Review.
-
Interindividual differences in aronia juice tolerability linked to gut microbiome and metabolome changes-secondary analysis of a randomized placebo-controlled parallel intervention trial.Microbiome. 2024 Mar 9;12(1):49. doi: 10.1186/s40168-024-01774-4. Microbiome. 2024. PMID: 38461313 Free PMC article. Clinical Trial.
-
Single anthocyanins effectiveness modulating inflammation markers in obesity: dosage and matrix composition analysis.Front Nutr. 2023 Nov 2;10:1255518. doi: 10.3389/fnut.2023.1255518. eCollection 2023. Front Nutr. 2023. PMID: 38024376 Free PMC article. Review.
-
Aronia in the Type 2 Diabetes Treatment Regimen.Nutrients. 2023 Sep 28;15(19):4188. doi: 10.3390/nu15194188. Nutrients. 2023. PMID: 37836472 Free PMC article. Clinical Trial.
-
Effects of anthocyanin supplementation on blood lipid levels: a systematic review and meta-analysis.Front Nutr. 2023 Aug 15;10:1207751. doi: 10.3389/fnut.2023.1207751. eCollection 2023. Front Nutr. 2023. PMID: 37649528 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical